IDiyas

For the Inventor, By the Inventor

Marlborough, MA, United States of America

Mariusz Krawiec

LinkedIn
USPTO Granted Patents = 31 


 

Average Co-Inventor Count = 4.3

ph-index = 22

Forward Citations = 1,462(Granted Patents)


Company Filing History:

goldMedal31 out of 1,149 
 
Vertex Pharmaceuticals, Inc.
 patents

Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents
1. 12065432 - Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid (2024-08-20),
2. 11578062 - Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2023-02-14),
3. 11291662 - Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2022-04-05),
4. 10906891 - Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2021-02-02),
5. 10597384 - Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid (2020-03-24),
6. 10537565 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2020-01-21),
7. 10081621 - Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2018-09-25),
8. 9931334 - Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2018-04-03),
9. 9840499 - Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid (2017-12-12),
10. 9670163 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2017-06-06),
11. 9434717 - Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid (2016-09-06),
12. 9314455 - Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (2016-04-19),
13. 9150552 - Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid (2015-10-06),
14. 9139530 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2015-09-22),
15. 9051303 - [object Object] (2015-06-09),

Title: Mariusz Krawiec: Innovator in Pharmaceutical Chemistry

Introduction

Mariusz Krawiec, based in Marlborough, Massachusetts, is an accomplished inventor with a significant portfolio of 31 patents. His contributions primarily focus on innovative pharmaceutical compounds and formulations, reflecting his dedication to advancing medicinal chemistry.

Latest Patents

Mariusz Krawiec's recent patented innovations include:

1. **Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid** - This invention pertains to a substantially crystalline and free solid-state form of the compound, along with pharmaceutical compositions and methods for treatment.

2. **Solid forms of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide** - This patent describes solid forms in substantially crystalline form or amorphous form, complete with pharmaceutical compositions and treatment methodologies.

Career Highlights

Mariusz has demonstrated his expertise while working at prominent companies such as Vertex Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated. His focus on developing novel pharmaceutical solutions has likely contributed to better treatment options in the industry.

Collaborations

Throughout his career, Mariusz Krawiec has collaborated with talented professionals, including Beili Zhang and Ali Keshavarz-Shokri. These collaborations have undoubtedly enhanced innovation and research within the pharmaceutical field.

Conclusion

Mariusz Krawiec stands out as a key innovator in the field of pharmaceutical chemistry, with a rich array of patents that push the boundaries of medicinal development. His work continues to make significant strides in providing better therapeutic options, demonstrating the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…